Gestational Age Specific Thyroid Function Reference Range
1 other identifier
observational
599
0 countries
N/A
Brief Summary
It has been well accepted that maternal thyroid dysfunction has adverse affects on both mothers and fetuses. However, the dramatical changes during pregnancy make the interpretation of thyroid function test (TFT, i.e. free triiodothyronine \[FT3\], free thyroxine \[FT4\] and thyrotropin \[TSH\]) very difficult. Previous studies have shown that the level of thyroid hormones differs from non-pregnant population and varies from gestational ages. Moreover, studies have shown the agreement among different instrument platforms was quite low. This study is aimed to determine gestational age specific TFT reference ranges of the local pregnant population for all available platforms currently used under Hospital Authority and Department of Health.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2014
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 2, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2016
CompletedFirst Submitted
Initial submission to the registry
August 21, 2018
CompletedFirst Posted
Study publicly available on registry
September 10, 2018
CompletedSeptember 10, 2018
September 1, 2018
1.8 years
August 21, 2018
September 6, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Change of free triiodothyronine (FT3) during pregnancy
gestational FT3 level
At the time of booking for antenatal visit (1st trimester), oral glucose tolerance test (24-32 weeks), admission for delivery (3rd trimester) and a gestational age assigned randomly.
Change of free thyroxine (FT4) during pregnancy
gestational FT4 level
At the time of booking for antenatal visit (1st trimester), oral glucose tolerance test (24-32 weeks), admission for delivery (3rd trimester) and a gestational age assigned randomly.
Change of thyrotropin (TSH) during pregnancy
gestational TSH level
At the time of booking for antenatal visit (1st trimester), oral glucose tolerance test (24-32 weeks), admission for delivery (3rd trimester) and a gestational age assigned randomly.
Study Arms (1)
pregnant women
pregnant women in Hong Kong
Eligibility Criteria
Hong Kong women
You may qualify if:
- Pregnant women receiving pregnancy and postnatal care in the Department of Obstetrics \& Gynaecology, Prince of Wales Hospital, Hong Kong
You may not qualify if:
- \. Previous history of thyroid dysfunction (hypothyroidism or hyperthyroidism);
- \. Autoimmune disease, particularly those receiving corticosteroid or immunosuppressant: e.g. systemic lupus erythematosus;
- \. Disease associated with thyroid dysfunction: e.g. molar pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Biospecimen
Cord blood
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Wing Hung Tam, MD
Chinese University of Hong Kong
Study Design
- Study Type
- observational
- Observational Model
- ECOLOGIC OR COMMUNITY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
August 21, 2018
First Posted
September 10, 2018
Study Start
July 2, 2014
Primary Completion
April 30, 2016
Study Completion
April 30, 2016
Last Updated
September 10, 2018
Record last verified: 2018-09